Drug maker Eli Lilly & Co. said Friday it is in advanced talks with the Securities and Exchange Commission to resolve a probe into potential violations of a US law prohibiting bribery of foreign officials.
Drug maker Eli Lilly & Co. said Friday it is in advanced talks with the Securities and Exchange Commission to resolve a probe into potential violations of a US law prohibiting bribery of foreign officials.